Published in J Psychiatry Neurosci on May 01, 2006
Sample matching by inferred agonal stress in gene expression analyses of the brain. BMC Genomics (2007) 1.54
Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry (2008) 1.41
Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol (2010) 1.19
Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One (2008) 1.17
Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis (2011) 1.11
Systematic review of genome-wide gene expression studies of bipolar disorder. BMC Psychiatry (2013) 1.06
N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice. Neuropsychopharmacology (2011) 1.02
Inositol-related gene knockouts mimic lithium's effect on mitochondrial function. Neuropsychopharmacology (2013) 0.97
3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci (2009) 0.97
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med (2015) 0.94
Increased peripheral blood expression of electron transport chain genes in bipolar depression. Bipolar Disord (2010) 0.94
Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J Psychiatry Neurosci (2010) 0.93
Oxidative stress in early stage Bipolar Disorder and the association with response to lithium. J Psychiatr Res (2013) 0.90
Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder. Expert Opin Ther Targets (2014) 0.89
Is bipolar disorder a mitochondrial disease? J Psychiatry Neurosci (2007) 0.88
The somatic common deletion in mitochondrial DNA is decreased in schizophrenia. Schizophr Res (2014) 0.87
Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. Front Cell Neurosci (2013) 0.87
Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models. Neurobiol Dis (2011) 0.86
Upstream Pathways Controlling Mitochondrial Function in Major Psychosis: A Focus on Bipolar Disorder. Can J Psychiatry (2016) 0.84
Meta-Analysis of Gene Expression in Autism Spectrum Disorder. Autism Res (2015) 0.81
Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes. Psychopharmacology (Berl) (2014) 0.81
Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis. Mol Psychiatry (2016) 0.81
Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders. Mol Psychiatry (2015) 0.80
A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia. Neuropsychopharmacology (2013) 0.80
Lithium reduces the effects of rotenone-induced complex I dysfunction on DNA methylation and hydroxymethylation in rat cortical primary neurons. Psychopharmacology (Berl) (2014) 0.80
Lithium: a key to the genetics of bipolar disorder. Genome Med (2009) 0.80
Cross-species toxicogenomic analyses and phenotypic anchoring in response to groundwater low-level pollution. BMC Genomics (2014) 0.80
Differential hippocampal gene expression and pathway analysis in an etiology-based mouse model of major depressive disorder. Am J Med Genet B Neuropsychiatr Genet (2014) 0.79
Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus-31 magnetic resonance spectroscopy study. Bipolar Disord (2012) 0.78
Mitochondrial dysfunction in schizophrenia: an evolutionary perspective. Hum Genet (2014) 0.78
Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects. Neuropsychiatr Dis Treat (2015) 0.77
Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD). Behav Brain Funct (2014) 0.77
Dorsal Anterior Cingulate Lactate and Glutathione Levels in Euthymic Bipolar I Disorder: 1H-MRS Study. Int J Neuropsychopharmacol (2016) 0.77
Calcium-dependent intracellular signal pathways in primary cultured adipocytes and ANK3 gene variation in patients with bipolar disorder and healthy controls. Mol Psychiatry (2014) 0.76
Identification of collaborative activities with oxidative phosphorylation in bipolar disorder. Bioinformation (2015) 0.76
Evaluation of brain creatine kinase activity in an animal model of mania induced by ouabain. J Neural Transm (Vienna) (2010) 0.76
Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Bipolar Disorder Normalizes after Zinc and Anti-oxidant Therapy. Nutr Metab Insights (2010) 0.75
Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges. Front Cell Neurosci (2017) 0.75
Altered prefrontal lobe oxygenation in bipolar disorder: a study by near-infrared spectroscopy. Psychol Med (2008) 0.75
Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study. J Clin Psychopharmacol (2016) 0.75
The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence. Front Neurosci (2017) 0.75
The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence. Mol Neurobiol (2016) 0.75
Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (N Y) (1993) 22.41
Fundamentals of experimental design for cDNA microarrays. Nat Genet (2002) 7.49
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A (2001) 6.68
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry (2004) 3.90
The stanley foundation brain collection and neuropathology consortium. Schizophr Res (2000) 3.37
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
Frontal lobe and cognitive development. J Neurocytol (2003) 2.92
The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry (2001) 2.69
Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet (2004) 2.33
Mitochondrial dysfunction in bipolar disorder. Bipolar Disord (2000) 2.32
Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry (2001) 2.32
Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet (2004) 2.31
Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry (2004) 2.27
Universal Reference RNA as a standard for microarray experiments. BMC Genomics (2004) 2.00
Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry (2004) 1.95
Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry (1998) 1.94
Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry (2004) 1.89
Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs (2003) 1.41
The functional neuroanatomy of mood disorders. J Psychiatr Res (1998) 1.40
Signaling by reactive oxygen species in the nervous system. Cell Mol Life Sci (2000) 1.27
Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J Affect Disord (1993) 1.14
The neurobiology of bipolar disorder: focus on signal transduction pathways and the regulation of gene expression. Can J Psychiatry (2002) 1.12
Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry (2005) 1.08
Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin Neurosci (2004) 1.08
Neuropathology of bipolar disorder. Biol Psychiatry (2000) 1.00
The nature of bipolar disorder. J Clin Psychiatry (2000) 0.97
Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration. Brain Res Bull (2002) 0.96
Cortical influences in emotion. J Clin Neurophysiol (1998) 0.95
Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex. J Neurochem (2001) 0.93
Magnetic resonance spectroscopy in affective disorders. J Neuropsychiatry Clin Neurosci (1998) 0.92
Decreased temporal lobe phosphomonoesters in bipolar disorder. J Affect Disord (1995) 0.85
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord (2005) 4.94
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord (2009) 3.56
Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A (2003) 3.29
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord (2012) 3.01
Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology (2007) 2.02
Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings. Am J Psychiatry (2006) 1.84
Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol (2010) 1.56
Brain structural signature of familial predisposition for bipolar disorder: replicable evidence for involvement of the right inferior frontal gyrus. Biol Psychiatry (2012) 1.47
Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord (2008) 1.46
Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry (2004) 1.42
Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci U S A (2004) 1.37
Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry (2010) 1.36
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol (2008) 1.30
A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME]. J Clin Psychiatry (2012) 1.30
Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization. Eur J Pharm Biopharm (2008) 1.24
Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study. Psychopharmacology (Berl) (2007) 1.17
Subsyndromal symptoms assessed in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder. Bipolar Disord (2003) 1.16
Acute and chronic restraint stress alter the incidence of social conflict in male rats. Horm Behav (2003) 1.16
Treatment-specific changes in decentering following mindfulness-based cognitive therapy versus antidepressant medication or placebo for prevention of depressive relapse. J Consult Clin Psychol (2012) 1.15
The neurobiology of bipolar disorder: focus on signal transduction pathways and the regulation of gene expression. Can J Psychiatry (2002) 1.12
Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry (2013) 1.12
Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry (2005) 1.08
Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment. Biol Psychiatry (2004) 1.03
Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord (2012) 1.02
Lithium response and genetic variation in the CREB family of genes. Am J Med Genet B Neuropsychiatr Genet (2008) 1.01
Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons. J Neurochem (2004) 0.99
The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology (2010) 0.98
Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord (2009) 0.97
3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci (2009) 0.97
Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.95
Implication of synapse-related genes in bipolar disorder by linkage and gene expression analyses. Int J Neuropsychopharmacol (2010) 0.95
Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J Psychiatry Neurosci (2010) 0.93
Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study. J Psychiatry Neurosci (2012) 0.93
Desipramine treatment reduces the long-term behavioural and neurochemical sequelae of early-life maternal separation. Int J Neuropsychopharmacol (2003) 0.93
Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem (2013) 0.93
A pilot study of visual backward masking performance among affected versus unaffected offspring of parents with bipolar disorder. Bipolar Disord (2004) 0.91
Facile synthesis of gamma-alkylidenebutenolides. Org Biomol Chem (2007) 0.91
Chronic restraint stress decreases the expression of glutathione S-transferase pi2 in the mouse hippocampus. Brain Res (2006) 0.91
Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells. Life Sci (2005) 0.90
Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment. Bipolar Disord (2012) 0.90
Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia. Int J Neuropsychopharmacol (2011) 0.90
Longitudinal outcome in patients with bipolar disorder assessed by life-charting is influenced by DSM-IV personality disorder symptoms. Bipolar Disord (2003) 0.89
Regulation of ER stress proteins by valproate: therapeutic implications. Bipolar Disord (2002) 0.89
A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression. World J Biol Psychiatry (2011) 0.89
Impact of simulated microgravity on microvascular endothelial cell apoptosis. Eur J Appl Physiol (2011) 0.88
cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment. J Neurochem (2002) 0.88
Is bipolar disorder a mitochondrial disease? J Psychiatry Neurosci (2007) 0.88
Doxorubicin-induced thymus senescence. J Proteome Res (2010) 0.87
Neuroprotective effects of antidepressant and mood stabilizing drugs. J Psychiatry Neurosci (2002) 0.86
Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function. Curr Psychiatry Rep (2013) 0.86
Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder. Ann N Y Acad Sci (2011) 0.86
Cortical inhibitory dysfunction in bipolar disorder: a study using transcranial magnetic stimulation. J Clin Psychopharmacol (2007) 0.85
A fresh look at complex I in microarray data: clues to understanding disease-specific mitochondrial alterations in bipolar disorder. Biol Psychiatry (2012) 0.85
Synthesis of andrographolide derivatives: a new family of alpha-glucosidase inhibitors. Bioorg Med Chem (2007) 0.84
Toxicogenomic responses of the model organism Caenorhabditis elegans to gold nanoparticles. Environ Sci Technol (2012) 0.84
Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia. Neurosci Lett (2006) 0.84
Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy. CNS Drugs (2002) 0.84
Unpredictable chronic mild stress not chronic restraint stress induces depressive behaviours in mice. Neuroreport (2014) 0.83
Alterations in phosphorylated cAMP response element-binding protein (pCREB) signaling: an endophenotype of lithium-responsive bipolar disorder? Bipolar Disord (2013) 0.83
Identification of lithium-regulated genes in cultured lymphoblasts of lithium responsive subjects with bipolar disorder. Neuropsychopharmacology (2004) 0.83
Neuron somal size is decreased in the lateral amygdalar nucleus of subjects with bipolar disorder. J Psychiatry Neurosci (2007) 0.83
Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder. Int J Neuropsychopharmacol (2013) 0.83
[An experimental study on the repair mechanism after pulmonary embolism]. Zhonghua Jie He He Hu Xi Za Zhi (2004) 0.82
Chronic lithium treatment inhibits pilocarpine-induced mossy fiber sprouting in rat hippocampus. Neuropsychopharmacology (2003) 0.82
Wilson's disease: update on integrated Chinese and Western medicine. Chin J Integr Med (2012) 0.82
Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity. Pharmazie (2014) 0.82
Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells. Biol Psychiatry (2003) 0.81
Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain. Psychopharmacology (Berl) (2013) 0.81
Immunological and neurotrophic markers of risk status and illness development in high-risk youth: understanding the neurobiological underpinnings of bipolar disorder. Int J Bipolar Disord (2014) 0.81
BDNF protein levels are decreased in transformed lymphoblasts from lithium-responsive patients with bipolar disorder. J Psychiatry Neurosci (2008) 0.80
Lithium reduces the effects of rotenone-induced complex I dysfunction on DNA methylation and hydroxymethylation in rat cortical primary neurons. Psychopharmacology (Berl) (2014) 0.80
Inhibition of glycogen synthase kinase-3 enhances the differentiation and reduces the proliferation of adult human olfactory epithelium neural precursors. Exp Cell Res (2011) 0.80
Heme oxygenase-1 system, inflammation and ventilator-induced lung injury. Eur J Pharmacol (2011) 0.79
Signal transduction pathways in the pathophysiology of bipolar disorder. Curr Top Behav Neurosci (2011) 0.79
Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment. Brain Res (2007) 0.79
Lamotrigine increases gene expression of GABA-A receptor beta3 subunit in primary cultured rat hippocampus cells. Neuropsychopharmacology (2002) 0.79
The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future. Bipolar Disord (2013) 0.79
Insulin-like growth factor binding protein-2 expression is decreased by lithium. Neuroreport (2006) 0.79
What exactly is a mood stabilizer? J Psychiatry Neurosci (2004) 0.78
Studies on the novel alpha-glucosidase inhibitory activity and structure-activity relationships for andrographolide analogues. Bioorg Med Chem Lett (2006) 0.78
The roles of MMP-9/TIMP-1 in cerebral edema following experimental acute cerebral infarction in rats. Neurosci Lett (2013) 0.77
Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex. Int J Neuropsychopharmacol (2011) 0.77
Mood stabilizing drugs lamotrigine and olanzapine increase expression and activity of glutathione S-transferase in primary cultured rat cerebral cortical cells. Neurosci Lett (2009) 0.77
What is the best treatment for bipolar depression? J Psychiatry Neurosci (2008) 0.77